NEW YORK, March 25, 2015 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of Illinois on behalf of investors who purchased Akorn, Inc. ("Akorn" or the "Company") (Nasdaq: AKRX ) securities pursuant and/or traceable to the Initial Public Offering on or about June 26, 2014.
Click here to learn about the case: http://docs.wongesq.com/AKRX-Info-Request-Form-661 . There is no cost or obligation to you.
The complaint alleges that: (a) as of December 31, 2014 Akorn has yet to integrate subsidiaries Hi-Tech Pharmacal Co., Inc. and VersaPharm Incorporated into its centralized accounting department and accounting systems; (b) certain data related to these subsidiaries could not be timely collected and compiled; and (c) Akorn's internal control over financial reporting was ineffective and material weaknesses existed relating to the completeness and accuracy of underlying data used in the determination of significant estimates and accounting transactions and accurate and timely reporting of its financial results and disclosures in its Form 10-K.
If you suffered a loss in Akorn you have until May 4, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com , by telephone at 212.425.1140, or visit http://docs.wongesq.com/AKRX-Info-Request-Form-661 .
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: